扩展现实游戏用于整个儿科癌症康复期间的炼和正念:随机对照试验的协议
Byron Lai1, Kelli Chaviano1, Joshua S Richman2
1Division of Pediatric Rehabilitation Medicine, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, United States.
JMIR research protocols
|December 23, 2024
概括
这项试点研究探讨了一个扩展现实 (ER) 计划,以改善骨髓移植的儿科癌症患者的身体和精神健康. 这项为期14周的计划使用沉浸式游戏和正念来增强康复结果.
科学领域:
- 康复医学 康复医学 康复医学
- 儿科瘤学 儿科瘤学
- 数字健康数字健康
背景情况:
- 儿童癌症患者在医院治疗期间和之后面临着自我管理健康的挑战.
- 扩展现实 (ER) 为临床环境中的疼痛管理,心理健康和身体活动提供了沉浸式解决方案.
- 对于儿童癌症康复来说,没有确立的ER协议,以改善身体和心理健康.
研究的目的:
- 调查14周ER计划对儿童癌症患者体力活动和健康指标的影响骨髓移植后.
- 评估ER计划的可行性和参与者的参与.
主要方法:
- 一项试点随机对照试验,采用1组交叉设计,涉及16名儿科癌症患者 (≥8岁).
- 两个组:即时的急救干预 (医院和家庭) 与常规护理等候名单控制.
- 干预包括积极的视频游戏,正念和行为指导;通过加速度计测量身体活动;使用PROMIS秤和螺旋计评估健康结果.
主要成果:
- 研究资助于2024年2月,招聘开始于2024年6月.
- 数据收集预计将在2026年2月之前完成,结果将在2026年3月之前进行分析并提交.
- 预计研究完成日期为2026年3月31日.
结论:
- 本试验评估了一种可访问的远程ER程序,旨在增强儿科癌症患者的身体和精神健康.
- 结果将指导对这一群体进行更大规模的临床试验.
相关概念视频
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...